Last updated: May 26, 2026
Sterile Water for Injection (SWFI) in a plastic container is widely supplied by large sterile injectables manufacturers, specialty API-to-fills houses, and regional distributors. In the US, the supply chain is anchored by companies that produce Water for Injection under USP and package it into final SWFI containers (typically flexible plastic bags or other plastic primary packaging), then sell through wholesalers and distributors to hospitals and health systems.
What matters for sourcing: USP compliance, container system, lot traceability, FDA establishment registration, and whether the product is supplied as hospital distribution units or patient-care packaging. Competitive risk concentrates in the manufacturing slots for sterile aseptic filling and plastic bag/container line clearance.
Which companies supply Sterile Water for Injection (SWFI) in plastic containers?
Quick answer: SWFI is supplied by multiple incumbent sterile injectables manufacturers and branded generics producers that fill in plastic containers, with parallel distribution via wholesalers and specialty channels. The most reliable sourcing comes from (1) FDA-registered sterile injectables plants producing the final filled drug product and (2) distributors who maintain continuous allocation or safety stock.
Common supplier categories
- Large sterile injectables manufacturers (finished drug product producer): produce and package SWFI into plastic primary containers under GMP.
- Specialty sterile filling providers (co-packer model): may fill and finish SWFI for brands or distributors.
- US wholesalers and specialty distributors (logistics): sell and allocate SWFI sourced from one or more finished-goods manufacturers.
Preferred due-diligence checkpoints for suppliers
- FDA registration and GMP inspection history of the final drug product establishment.
- USP conformance for Water for Injection and final SWFI labeling.
- Plastic container system type (bag, single-dose container format, and compatibility).
- Nitrogen/overwrap and storage controls that align with hospital handling requirements.
- Lot traceability including container code and expiration labeling.
What suppliers make Sterile Water for Injection in plastic bags vs other plastic containers?
Quick answer: Most hospital use is dominated by SWFI in flexible plastic bags and single-dose plastic container formats, supplied by sterile filling lines that support aseptic filling into flexible or molded plastic primary packaging.
Plastic bag SWFI: typical supply chain
- Aseptic filling into flexible plastic containers
- Leak-proofing and sterilization validation
- Packaging in cartons for hospital distribution
Single-dose plastic containers: supply chain
- Aseptic filling into small-volume plastic containers
- Tamper-evident packaging and unit labeling
- More frequent substitution during shortages due to line availability
How many suppliers exist for SWFI in plastic containers in the US market?
Quick answer: The US market has a broad supplier base, but the number of finished-goods producers with steady aseptic sterile filling capacity is smaller than the number of distributors. Shortages usually reflect limited filling line capacity or raw material and container component constraints, not demand collapse.
Market structure drivers
- Container manufacturing and sterile assembly are constrained by aseptic line availability.
- SWFI is simple, but sterile filtration, aseptic technique, and container compatibility requirements still drive limited capacity.
- Allocation risk rises when multiple SKUs and strengths are produced on shared lines.
What is the FDA and USP status of Sterile Water for Injection in plastic containers?
Quick answer: SWFI is a USP-defined sterile product. In the US it is regulated as a drug (sterile injectable), and the final packaged product must meet USP standards and be manufactured under FDA GMP.
Key regulatory points
- USP monograph compliance: Water for Injection / Sterile Water for Injection requirements.
- GMP compliance at the drug product manufacturing site.
- FDA establishment registration for the final dosage form manufacturing.
- Labeling and container compliance with stability and compatibility requirements.
What FDA labeling and container requirements affect SWFI suppliers?
Quick answer: The container and labeling requirements are central for procurement. Hospitals and distribution channels typically prioritize container integrity, clarity of labeling, expiration, and scannable lot traceability.
Procurement-critical labeling elements
- Strength and volume (eg, 50 mL, 100 mL, 250 mL, 500 mL, 1000 mL depending on SKU)
- “Sterile Water for Injection” statement
- Storage requirements
- Lot number and expiration date
- Container type and usage instructions consistent with compatibility guidance
Which suppliers are most exposed during SWFI shortages in plastic containers?
Quick answer: Exposure concentrates among manufacturers tied to the same aseptic filling or plastic container line capacity and among distributors that rely on a small upstream set of finished-goods producers.
Shortage exposure indicators
- Public shortage listings tied to sterile injectables capacity
- Manufacturing site concentration
- Limited alternative container formats or line-clearance constraints
What generic and branded suppliers compete for SWFI in plastic containers?
Quick answer: Competition is primarily “generic SWFI” across multiple manufacturers, with branded availability depending on historical labeling and distribution relationships. The procurement reality is that buyers typically source by NDC and pack size more than by “brand.”
How buyers reduce risk
- Maintain at least two approved upstream manufacturers
- Qualify alternate container types (bag size vs unit-dose plastics) when clinically acceptable
- Require lot traceability and consistent labeling format
What supply and manufacturing/IP barriers exist for SWFI in plastic containers?
Quick answer: For SWFI, the barrier is less about patent exclusivity and more about sterile manufacturing capacity, aseptic line validation, and container system qualification.
Practical barriers
- Aseptic filling line capacity constraints
- Container component availability
- Sterility assurance testing cadence and validation scope
- Compatibility testing for plastic container materials
How do SWFI plastic container suppliers support hospital contracting and distribution?
Quick answer: Suppliers typically support hospitals through GPO and direct distributor channels. The differentiators are allocation policies, consistent case pack supply, and ability to meet specific NDC requirements.
Commercial support points
- Contract compliance (NDC continuity, substitution rules)
- Forecasting and safety stock
- Allocation management during constrained supply
Key Takeaways
- SWFI in plastic containers is supplied by multiple incumbent sterile injectables manufacturers, with final product made under GMP in FDA-registered facilities and distributed through wholesalers and health system channels.
- Procurement risk concentrates in aseptic filling capacity and plastic container system qualification, not in licensing or patent exclusivity.
- Supplier qualification should emphasize container system integrity, lot traceability, USP compliance, and continuous availability via a diversified upstream base.
- During shortages, exposure concentrates among manufacturers sharing constrained aseptic line capacity and distributors dependent on a narrow upstream supply set.
FAQs
- How do I qualify alternate plastic container sizes for Sterile Water for Injection in hospital protocols?
- What documentation should procurement request from SWFI plastic container suppliers (USP, lot traceability, stability)?
- Which factors drive Sterile Water for Injection allocations during shortages?
- How can distributors reduce SWFI risk when a single manufacturer’s line is down?
- Does container material type impact compatibility for SWFI use as diluent for injectable drugs?
References (APA)
- U.S. Food and Drug Administration. (n.d.). Drug shortages. https://www.fda.gov/drugs/drug-safety-and-availability/drug-shortages
- U.S. Food and Drug Administration. (n.d.). Drugs@FDA. https://www.accessdata.fda.gov/scripts/cder/daf/
- United States Pharmacopeia. (current edition). Water for Injection and Sterile Water for Injection. USP Monographs.
